Plan for shared evidence
Global regulatory harmonization creates opportunities to reuse evidence and align quality practices. It does not eliminate national approval decisions. MedTech teams still need market-specific strategies and a clear understanding of where requirements converge and where they remain distinct.
Connect the operating model
The source perspective discusses FDA quality-system alignment, MDSAP, standardized submission formats, and earlier regulator engagement. The operating implication is broader than regulatory affairs: connect R&D, quality, clinical, operations, and commercial teams before development decisions harden.
Start with ownership
Plan human factors, cybersecurity, software, and AI governance for global reuse where appropriate. Strengthen the quality system and assign responsibility for cross-functional handoffs. Treat this as a dated strategic perspective, and confirm applicable requirements and implementation dates before using it for a regulatory decision.